2020
DOI: 10.1177/0003134820947371
|View full text |Cite
|
Sign up to set email alerts
|

Meta-Analysis on the Effect of Pasireotide for Prevention of Postoperative Pancreatic Fistula

Abstract: Background A randomized controlled trial of routine administration of pasireotide demonstrated decreased incidence of clinically significant postoperative pancreatic fistula (POPF). Recent studies have not replicated these results. A meta-analysis was performed to evaluate its efficacy in this setting. Methods Prospective trials utilizing pasireotide prophylactically after pancreatectomy were reviewed. The primary outcome was clinically significant POPF. Secondary outcomes included length of stay (LOS), readmi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 26 publications
(57 reference statements)
0
5
0
Order By: Relevance
“…This prompted use in patients undergoing pancreatectomy, where perioperative pasireotide was associated with a relative risk of 0.44 (95% confident interval 0.24-0.78) in reducing postoperative leak, fistula, or abscess as compared to placebo ( 9 ). In meta-analysis this was suggested but did not reach statistical significance ( 10 ).…”
Section: Discussionmentioning
confidence: 99%
“…This prompted use in patients undergoing pancreatectomy, where perioperative pasireotide was associated with a relative risk of 0.44 (95% confident interval 0.24-0.78) in reducing postoperative leak, fistula, or abscess as compared to placebo ( 9 ). In meta-analysis this was suggested but did not reach statistical significance ( 10 ).…”
Section: Discussionmentioning
confidence: 99%
“…However, few studies have focused on stump closure management, particularly in the soft pancreas, which is one of the most critical topics. This complication depends on intrinsic characteristics such as pancreatic parenchyma [37], pancreatic duct size [38], and pasireotide use [39]. Several surgeons have suggested a variety of intraoperative procedures to reduce the POPF rate.…”
Section: Discussionmentioning
confidence: 99%
“…[60]. And, the effectiveness of preventive application of pasiresotide and negative pressure drainage to reduce the incidence of pancreatic fistula, have been proved effective in recent reports respectively [61,62]. In addition, other reports also show the effectiveness of some treatments to postoperatively mitigate pancreatic fistula, such as hydrocortisone, and so-called triple drug therapy (TDT, including gabexate mesilate, octreotide, and carbapenem antibiotics) [63,64].…”
Section: Discussionmentioning
confidence: 99%